Home
Two-Year Phase III Data Presented At AAN 61st Annual Meeting Show Positive Outcome Of Cladribine Tablets In Patients With Multiple Sclerosis

Two-Year Phase III Data Presented At AAN 61st Annual Meeting Show Positive Outcome Of Cladribine Tablets In Patients With Multiple Sclerosis

Apr 30 2009 | comment(s)

SEATTLE and GENEVA, April 30 /PRNewswire/ --

- Primary Endpoint met With a Significant Reduction in Relapse Rate - Secondary Endpoints met Including MRI Measures, Proportion of Patients Relapse-Free and Disability Progression - Submission for Registration of Cladribine Tablets Planned for mid-2009

MS Society Statement On Oral Therapy Results

MS Society Statement On Oral Therapy Results

Apr 30 2009 | comment(s)

LONDON, April 30 /PRNewswire/ --

LONDON, April 30 /PRNewswire/ --

Following the embargoed news released by the Queen Mary University of London concerning the oral MS drug cladribine and the results due to be presented at the American Academy of Neurology meeting, please find below a statement from the MS Society.

Dr Lee Dunster, Head of Research at the MS Society, said: These are remarkable results and being able to take a tablet instead of having injections will be a huge step forward for people with MS.

The evidence is there, but we now need to see cladribine move smoothly through the regulatory process and the price the manufacturer sets will play a crucial part in that.

This week is MS Week. For more info, go to http://www.msweek.org.uk

Bosses Fed Up To The Back Teeth With Staff Dental Appointments

Bosses Fed Up To The Back Teeth With Staff Dental Appointments

Apr 30 2009 | comment(s)

ANDOVER, England, April 30 /PRNewswire/ --

Almost 1 in 8 managers in the UK has a problem trusting their staff when it comes to taking time off to visit the dentist, research released today reveals.

According to Simplyhealth's Annual Dental Survey, 13% of bosses dictate when employees can visit the dentist and in some cases, actively discourage any visits to the dentist during working hours.

But while many managers admit to subjecting their staff to high levels of scrutiny, the impact of employees not being given time to attend to dental matters threatens to have an adverse effect on their career.

Beautiful Shell Debris: CaCO3 Preservation

Beautiful Shell Debris: CaCO3 Preservation

Apr 29 2009 | comment(s)


Arctic Ice Core Proves Hot

Arctic Ice Core Proves Hot

Apr 29 2009 | comment(s)


Let's End Sexual Cannibalism

Let's End Sexual Cannibalism

Apr 29 2009 | comment(s)

At least once a year, Cosmo’s cover story is about how to have better, longer sex: a turgid treatise on positions and anatomy.  Our finest ladies’ mags are ignoring the obvious.

To improve the mating of our species, we must learn from the mistakes of garden spiders and band together to end sexual cannibalism once and for all.  

Female Argiope spiders only want what all of us want—the upper hand in the war of the sexes.  But your friendly neighborhood garden spider has more at stake than the proper replacement of the toilet seat. 
Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. As Chief Clinical Liaison

Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. As Chief Clinical Liaison

Apr 29 2009 | comment(s)

COMMACK, New York, April 29 /PRNewswire/ --

It is with great privilege that Avery Biomedical Devices, Inc. (ABD) announces the appointment of Abbott Krieger, M.D., F.A.C.S. as Chief Clinical Liaison.

Human Evolution - Petering Out?

Human Evolution - Petering Out?

Apr 29 2009 | comment(s)

Have we really stopped evolving? In Cosmos magazine, Steve Jones argues that human evolution is coming to an end:
The question I have is: will human evolution really continue? I think the evidence shows that human evolution has largely come to a halt.
He lists three components necessary for human evolution:
First of all there's variation, which comes from mutation. Second, natural selection, which comes from inherited differences between individuals and their ability to reproduce.
Harris Corporation Awarded US$20 Million Contract For Falcon II(R) And Falcon III(R) Tactical Radios From The Polish Ministry Of National Defense

Harris Corporation Awarded US$20 Million Contract For Falcon II(R) And Falcon III(R) Tactical Radios From The Polish Ministry Of National Defense

Apr 29 2009 | comment(s)

ROCHESTER, New York, April 29 /PRNewswire/ --

- Land and Special Operations Forces Will Acquire Harris Multiband and HF Technology to Enable Communications Interoperability for U.S., NATO and Coalition Operations

Harris Corporation (NYSE: HRS), an international communications and information technology company, has been awarded a contract totaling US$20 million from the Polish Ministry of National Defense (MoND) to deliver a combination of multiband and HF tactical radios for Poland's Land and Special Operations Command Forces.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090429/FL07552 )

Royal Pharmaceutical Society Of Great Britain Warns Against Counterfeit Drugs For H1N1 Influenza A (Swine Flu)

Royal Pharmaceutical Society Of Great Britain Warns Against Counterfeit Drugs For H1N1 Influenza A (Swine Flu)

Apr 29 2009 | comment(s)

When a fake pandemic is being generated by media corporations having a slow news week, fake medicine is sure to pop up and take advantage of it.   The Royal Pharmaceutical Society of Great Britain (RPSGB) today issued a warning to the public about the risks of buying online medicines for swine influenza, such as Tamiflu or Relenza.

David Pruce, RPSGB Director of Policy said, "With the current fears about swine flu, we are concerned that unscrupulous people are exploiting the public's fears about swine flu by offering to sell the antiviral drugs Tamiflu and Relenza over the internet.

"This is a golden opportunity for counterfeiters to offer fake supplies of these drugs.